Mark Batchelor - Concepedia

Author

Mark Batchelor

University College London ORCID

Also Known As

Batchelor, Mark, M. Batchelor, M. J. BATCHELOR, M.J. Batchelor, Mark Batchelor, Mark J Batchelor, Mark J. Batchelor

Publications

994

Citations

H-Index

Concepts

All Affiliations

University College London MRC Prion Unit National Hospital for Neurology and Neurosurgery Medical Research Council University of Sheffield

About

Mark Batchelor is an author at University College London specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	598
2	Natural Sciences	9	9	443
3	Biochemistry	9	9	382
4	Engineering	4	4	106
5	Biomedical Engineering	1	1	16

Mark Batchelor

Publications

973

Citations

H-Index

Page 1

	Year	Citations
Crystal structure of human prion protein bound to a therapeutic antibody S.V. Antonyuk, Clare R. Trevitt, R.W. Strange, Proceedings of the National Academy of Sciences Crystal StructureProtein FunctionNative PrpProtein AssemblyBiochemistry	2009	120
Recombinant prion protein does not possess SOD-1 activity Samantha W. Jones, Mark Batchelor, Daljit Bhelt, Biochemical Journal	2005	80
The Residue 129 Polymorphism in Human Prion Protein Does Not Confer Susceptibility to Creutzfeldt-Jakob Disease by Altering the Structure or Global Stability of PrPC Laszlo L. P. Hosszu, Graham S. Jackson, Clare R. Trevitt, Journal of Biological Chemistry Residue 129Creutzfeldt-jakob DiseaseHuman Prion ProteinProtein FoldingGenetics	2004	75
A novel application of the Dess-Martin reagent to the synthesis of an FK506 analogue and other tricarbonyl compounds Mark Batchelor, Roger J. Gillespie, Julian M.C. Golec, Tetrahedron Letters EngineeringOrganic ChemistryDess-martin ReagentSynthetic ChemistryChemistry	1993	63
Definable Equilibrium States in the Folding of Human Prion Protein Laszlo L. P. Hosszu, M A Wells, Graham S. Jackson, Biochemistry Protein AssemblyMolecular BiologyProtein Phase SeparationProtein RefoldingProtein Folding	2005	57
Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase John Porter, Simon Lumb, Fabien Lecomte, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryC-met KinaseNovel SeriesBiochemistry	2008	50
Desmin forms toxic, seeding-competent amyloid aggregates that persist in muscle fibers Niraja Kedia, Khalid Arhzaouy, Sara K. Pittman, Proceedings of the National Academy of Sciences	2019	45
4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase Rikki Alexander, Ahrani Balasundaram, Mark Batchelor, Bioorganic & Medicinal Chemistry Letters Pharmaceutical ChemistryMedicineMechanism Of ActionPharmacotherapyChemical Biology	2008	42
A Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models Stuart L. Emanuel, Robert H. Gruninger, Angel R. Fuentes‐Pesquera, Molecular Pharmacology	2004	41
A systematic investigation of production of synthetic prions from recombinant prion protein Christian Schmidt, Jérémie Fizet, Mark Batchelor, Open Biology	2015	41

Page 1